154 results
ARS
2023 FY
MYGN
Myriad Genetics, Inc.
17 Apr 24
Annual report to shareholders
4:33pm
assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b … a personalized five-year and lifetime assessment of the risk of developing breast cancer—regardless of ancestry. BRACAnalysis CDx® Germline Companion
8-K
EX-99.1
rtjst4vw
16 Jan 24
Results of Operations and Financial Condition
9:00am
8-K
EX-1.1
yan4el l99t0kxotf
13 Nov 23
Entry into a Material Definitive Agreement
4:31pm
S-3ASR
EX-4.3
a6q3v1qj
8 Nov 23
Automatic shelf registration
4:01pm
8-K
EX-99.1
clzwn5hsdtd4
6 Nov 23
Results of Operations and Financial Condition
4:05pm
8-K
qax0kz
6 Nov 23
Results of Operations and Financial Condition
4:05pm
8-K
EX-99.1
hgyka xdysoum
3 Aug 23
Results of Operations and Financial Condition
4:05pm
8-K
EX-10.1
upvwup
6 Jul 23
Entry into a Material Definitive Agreement
8:24am
8-K
EX-99.1
3v32gc
3 May 23
Results of Operations and Financial Condition
4:06pm